The new contracts address a long-standing demand for instruments that extend beyond standard high-yield and investment-grade markets. By integrating these products into a single clearing house, the firm aims to provide cross-margining benefits that free up significant capacity on institutional balance sheets. Ted Carey, Executive Director of Rates and OTC Products at CME Group, noted that the move is designed to provide the specific risk management tools institutions have been seeking.
Cameron Drinkwater, Chief Product and Operations Officer at S&P Dow Jones Indices, described the launch as a milestone for the U.S. leveraged loan sector. The partnership marks the first time an exchange-traded contract has been linked to a transparent, representative leveraged loan benchmark. Since the initial rollout of CME credit futures in June 2024, the complex has seen over 1.5 million contracts traded, with open interest surpassing $2 billion by September 2026. These instruments allow for automatic margin offsets against existing interest rate and equity futures, contributing to the $95 billion in daily capital efficiencies the company facilitates for its clients.
Comments (0)
No comments yet. Be the first!